Join to view full profile
3333 Burnet AveCincinnati, OH 45229
Phone+1 513-636-9985
Fax+1 513-636-7194
Dr. Frenck is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumResidency, Pediatrics, 1981 - 1984
McGovern Medical School at UTHealthClass of 1981
Certifications & Licensure
CA State Medical License 2004 - Present
KY State Medical License 2007 - 2027
OH State Medical License 2006 - 2027
IN State Medical License 2024 - 2025
VA State Medical License 1994 - 2008
TX State Medical License 1987 - 1994
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus
- Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3 Start of enrollment: 2013 Jan 07
- Phase I Norovirus Challenge Model Start of enrollment: 2022 Mar 28
Publications & Presentations
PubMed
- Evaluation of Three Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΔNS2/Δ1313/I1314L, RSV/6120/ΔNS2/1030s, and RSV/276 in RSV Seronegative Children.Coleen K Cunningham, Ruth A Karron, Elizabeth J McFarland, Mark J Giganti, Rachel Ketchum
The Journal of Infectious Diseases. 2026-10-03 - Seroprotection after measles vaccination in children with sickle cell anemia receiving hydroxyurea.Alexandra Power-Hays, Abigail Kincaid, Kathyrn E McElhinney, Teresa S Latham, Charles T Quinn
Blood Advances. 2026-09-22 - 3 citationsMucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.Robert L Atmar, Kirsten E Lyke, Christine M Posavad, Meagan E Deming, Rebecca C Brady
The Journal of Infectious Diseases. 2025-10-15
Journal Articles
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Robert W Frenck, Laura L Hammitt, The New England Journal of Medicine
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, Judith Absalon, Kathleen Neuzil, Vanessa Raabe, Philip R Dormitzer, The New England Journal of Medicine
Press Mentions
A New Vaccine Could Vanquish a Major Cause of Deadly Diarrheal DiseaseAugust 7th, 2026- Cincinnati Children's Opens New Pavilion to Continue Vaccine ResearchMay 6th, 2026
If Vaccine Data Doesn't Convince You, This Group Hopes a Grandmother's Story WillDecember 9th, 2025
Grant Support
- Vaccinology Training ProgramCINCINNATI CHILDRENS HOSP MED CTR2022–2027
- Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)CINCINNATI CHILDRENS HOSP MED CTR2019–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: